dMY Technology Group, Inc. IV (DMYQ.U) Prices Upsized $300M IPO
by Nicholas Alan Clayton on 2021-03-04 at 9:09pm

dMY Technology Group, Inc. IV. announced the pricing of its $300 million IPO and its units are expected to begin trading on the NYSE under the symbol “DMYQ.U,” Friday, March 5.

The new company aims to combine with a consumer-facing technology target valued between $1 billion and $3 billion. dMY IV is led by CEO Niccolo de Masi and Chairman Harry L. You.

Total SPAC deal count for 2021 year-to-date is now 221. This offering is expected to close on Tuesday, March 9.


Goldman Sachs & Co., LLC is acting as the sole bookrunner for the offering and Needham & Co., LLC is acting as co-manager of the offering. White & Case LLP is serving as Issuer’s Counsel with Ropes & Gray LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2025-04-23 at 6:13pm

New Providence Acquisition Corp. III (NASDAQ:NPACU) announced the pricing of its $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NPACU”, Thursday, April 24, 2025. The new SPAC aims to combine with a consumer target that has the potential to generate attractive risk-adjusted returns. New Providence III’s...

by Nicholas Alan Clayton on 2025-04-23 at 3:59pm

Cantor Equity Partners Inc. (NASDAQ:CEP) has entered into a definitive agreement to combine with Twenty One Capital at an enterprise value of $3.6 billion, or 1x its future net asset value (NAV). Twenty One Capital aims to secure a sizeable Bitcoin holding and leverage it for financial services products as well as Bitcoin-focused media offerings....

by Nicholas Alan Clayton on 2025-04-23 at 12:41pm

Voyager (NASDAQ:VACH) has signed a definitive agreement to combine with biotech firm VERAXA at an enterprise value of $1.38 billion. Heidelberg, Germany-based VERAXA is developing cancer treatments with its most advanced candidate targeting acute myeloid leukemia (AML). The combined company is expected to trade on the Nasdaq under the symbol “VERX” once the deal is...

by Nicholas Alan Clayton on 2025-04-23 at 8:22am

At the SPAC of Dawn SPACs announced two more business combinations and priced a IPO in the past 24 hours showing that activity is going to continue apace regardless of the present market volatility. Another major deal is rumored in the wind with Cantor Equity Partners I (NASDAQ:CEPO) reportedly nearing a major merger that would...

by Kristi Marvin on 2025-04-22 at 5:42pm

Texas Ventures Acquisition III Corp (NASDAQ:TVACU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TVACU”, Wednesday, April 23, 2025. The new SPAC’s primary search focus will be on industrial technology, specifically companies implementing advanced technologies including software, mobile and IoT applications,...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved